Key result
High bleeding risk defined by ARC-HBR criteria was associated with a higher cumulative incidence of BARC Type 3 or 5 bleeding events compared to non-high bleeding risk over a 7.5-year follow-up.
Why the study?
The validity of the Academic Research Consortium for High Bleeding Risk definitions of early, late, and very late bleeding events was unknown.
Does the ARC-HBR definition predict early, late, and very late bleeding events in patients implanted with second-generation DES?
Cohort (n=3,453)
No
Does the ARC-HBR definition predict early, late, and very late bleeding events in patients implanted with second-generation DES?
The ARC-HBR definition consistently identifies patients at high risk for long-term bleeding and ischemic events up to 7 years after second-generation DES implantation.
Answers are grounded in this paper and cite their sources.
ARC-HBR bleeding timing definitions require prospective validation; retrospective analysis leaves their utility open in DES patients.
BACKGROUND: The validity of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) definitions of early (<1 year), late (1-4 years), and very late (>4 years) bleeding events is unknown. METHODS AND RESULTS: This study was performed on patients (n=3,453) implanted with second-generation drug-eluting stents (DES) between 2010 and 2013. Data on all criteria of the ARC-HBR definition were collected retrospectively. The primary endpoint was Bleeding Academic Research Consortium Type 3 or 5 bleeding events; the ischemic endpoint was a composite of cardiac death, myocardial infarction, and ischemic stroke. The mean follow-up period was 7.5 years. Compared with non-high bleeding risk (HBR) patients, HBR patients (n=1,840; 53.3%) had an increased risk of the primary endpoint (early events, 3.6% vs. 0.5% [P<0.0001]; late events, 5.3% vs. 2.5% [P<0.0001]; very late events, 5.5% vs. 2.1% [P<0.0001]) and of ischemic events during follow-up. The discrimination ability of the ARC-HBR definition for late and very late bleeding events was comparable to that of early bleeding events (C statistics 0.679, 0.621, and 0.620, respectively) with high negative predictive value (96.6%, 95.1%, and 93.1%, respectively). Multivariate analysis revealed the different effects of individual criteria on bleeding events in each follow-up period. CONCLUSIONS: The ARC-HBR definition consistently identified patients at risk of long-term bleeding and ischemic events after second-generation DES implantation.
No takes yet. Share an insight, caveat, or question.
Miura et al. (2021) conducted a cohort in Coronary artery disease requiring percutaneous coronary intervention (n=3,453). High Bleeding Risk (ARC-HBR definition) vs. Non-High Bleeding Risk was evaluated on Bleeding Academic Research Consortium (BARC) Type 3 or 5 bleeding events (p=<0.0001). High bleeding risk defined by ARC-HBR criteria was associated with a higher cumulative incidence of BARC Type 3 or 5 bleeding events compared to non-high bleeding risk over a 7.5-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: